Clinical Validation of an Artificial Intelligence System for De-termining Fetal Lie and Position in 3rd Trimester
1 other identifier
observational
150
1 country
3
Brief Summary
This prospective clinical validation study aims to evaluate the diagnostic performance of an artificial intelligence (AI)-based navigational support system for determining fetal lie and presentation during third-trimester ultrasound examinations. Following routine clinical assessment by an expert clinician, three blind ultrasound sweeps will be obtained from each participant. The AI system will generate predictions of fetal lie and presentation from each sweep, which will be compared with the expert clinician's assessment as the reference standard. The study will also explore clinician perceptions of the system's usability and potential clinical value.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2025
CompletedFirst Submitted
Initial submission to the registry
August 4, 2026
CompletedFirst Posted
Study publicly available on registry
August 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
August 10, 2026
August 1, 2026
1.1 years
August 4, 2026
August 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of the AI navigational support system for determining fetal lie and presentation.
Overall proportion of correct AI predictions of fetal lie and presentation compared with expert clinician assessment (reference standard).
During the study ultrasound examination (approximately 5 minutes).
Secondary Outcomes (1)
Agreement between AI predictions and expert clinician assessment.
During the study ultrasound examination.
Study Arms (1)
Prospective Clinical Validation Cohort
Pregnant women with singleton pregnancies in the third trimester (≥28+0 weeks' gestation) undergoing obstetric ultrasound examination. Participants undergo three blind ultrasound sweeps, and AI-generated predictions of fetal lie and presentation are compared with expert clinician assessment.
Eligibility Criteria
Pregnant women with singleton pregnancies attending third-trimester ultrasound examinations at the Fetal Medicine Department, Rigshospitalet, Slagelse Hospital, or Hillerød Hospital.
You may qualify if:
- Pregnant women aged ≥18 years.
- Singleton pregnancy.
- Gestational age ≥28+0 weeks.
- Fetus in longitudinal lie (cephalic or breech presentation) as determined by the routine clinical ultrasound examination.
- Able to understand Danish or English.
- Able and willing to provide written informed consent.
You may not qualify if:
- Multiple pregnancy.
- Fetus in transverse lie.
- Inability to provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Nordsjællands Hospital, Department of Obstetrics and Gynecology
Hillerød, Capital Region, 3400, Denmark
Rigshospitalet - Department of Obstetrics and Gynecology
Copenhagen, København Ø, 2100, Denmark
Slagelse Hospital, Department of Obstetrics and Gynecology
Slagelse, 3450, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
August 4, 2026
First Posted
August 10, 2026
Study Start
September 11, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
August 10, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available because the dataset contains identifiable medical imaging data and is subject to Danish data protection regulations (GDPR).